v3.21.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues    
Operating expenses:        
Research and development 2,617,675 1,545,043 $ 5,272,447 $ 2,994,915
General and administrative 2,584,364 1,390,671 3,943,043 3,222,292
Total operating expenses 5,202,039 2,935,714 9,215,490 6,217,207
Operating loss (5,202,039) (2,935,714) (9,215,490) (6,217,207)
Other income (expense):        
Interest income (33) 1,743 3,140 37,195
Interest expense (10,425) (77,837) (24,985) (155,673)
Equity modification expense (998,643) (1,801,043)
Amortization of debt discount and offering costs (10,868) (92,078) (24,374) (183,361)
Total other expense (21,326) (1,166,815) (46,219) (2,102,882)
Net loss $ (5,223,365) $ (4,102,529) $ (9,261,709) $ (8,320,089)
Basic and diluted net loss per share (in Dollars per share) $ (0.08) $ (0.09) $ (0.15) $ (0.19)
Weighted average common shares outstanding - basic and diluted (in Shares) 61,860,023 43,336,953 61,710,979 43,228,161

Source